Breaking News Instant updates and real-time market news.

CHD

Church & Dwight

$49.63

-0.02 (-0.04%)

, NOMD

Nomad Foods

$17.95

0.1 (0.56%)

04:55
06/14/18
06/14
04:55
06/14/18
04:55

Deutsche Bank to hold a conference

Global Consumer Conference will be held in Paris, France on June 12-14.

CHD

Church & Dwight

$49.63

-0.02 (-0.04%)

NOMD

Nomad Foods

$17.95

0.1 (0.56%)

COTY

Coty

$14.01

-0.21 (-1.48%)

KORS

Michael Kors

$66.83

-1.34 (-1.97%)

HRL

Hormel Foods

$36.11

-0.25 (-0.69%)

EL

Estee Lauder

$155.63

-1.45 (-0.92%)

CCE

Coca-Cola European Partners

$39.43

0.63 (1.62%)

CL

Colgate-Palmolive

$63.04

-0.68 (-1.07%)

  • 14

    Jun

  • 15

    Jun

  • 19

    Jun

  • 26

    Jun

CHD Church & Dwight
$49.63

-0.02 (-0.04%)

05/07/18
MACQ
05/07/18
UPGRADE
MACQ
Outperform
Church & Dwight upgraded to Outperform from Neutral at Macquarie
05/07/18
05/07/18
UPGRADE
Target $55

Outperform
Church & Dwight upgraded to Outperform at Macquarie
As previously reported, Macquarie upgraded Church & Dwight to Outperform from Neutral and increased its price target to $55 from $50. Analyst Caroline Levy said the strong Q1 report demonstrated superior branding and execution, with above-peer organic growth providing confidence in Church & Dwight's agility in a tough environment.
04/20/18
DBAB
04/20/18
NO CHANGE
Target $80
DBAB
Hold
Deutsche Bank downgrades Procter & Gamble, Church & Dwight to Hold
Deutsche Bank analyst Steve Powers downgraded both Procter & Gamble (PG) and Church & Dwight (CHD) to Hold from Buy saying Household & Personal Care is "in a tough spot." The analyst expects incremental pricing pressure to build over the course of 2018 in many categories. Perhaps as a result of tax reform, combined with pre-existing competition, retailers and manufacturers seem willing to reinvest aggressively in order to preserve share, Powers tells investors in a research note. He views this as a "troublesome set-up" for Household & Personal Care names. Along with the two downgrades, the analyst lowered his price targets for Kimberly-Clark (KMB), Edgewell Personal (EPC), Colgate-Palmolive (CL) and Clorox (CLX).
04/20/18
DBAB
04/20/18
DOWNGRADE
Target $50
DBAB
Hold
Church & Dwight downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Stephen Powers downgraded Church & Dwight to Hold and lowered his price target for the shares to $50 from $56.
NOMD Nomad Foods
$17.95

0.1 (0.56%)

11/16/17
11/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Vantiv (VNTV) initiated with a Buy at Berenberg. 2. Sea Limited (SE) initiated with a Buy at Citi. 3. Nomad Foods (NOMD) initiated with a Buy at Berenberg. 4. Access National (ANCX) initiated with an Overweight at Stephens. 5. TPI Composites (TPIC) initiated with an Outperform at JMP Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/28/17
DBAB
11/28/17
NO CHANGE
Target $20
DBAB
Buy
Nomad Foods target raised to $20 on 'strong' Q3 at Deutsche Bank
Deutsche Bank analyst Rob Dickerson views Nomad Foods' Q3 results as "strong," saying organic sales were driven by company end-market share gains and an acceleration in frozen category growth. The analyst continues to recommend the shares and upped his price target to $20 from $18.
11/29/17
RHCO
11/29/17
NO CHANGE
Target $20
RHCO
Buy
Nomad Foods price target raised to $20 from $17 at SunTrust
SunTrust analyst William Chappell raised his price target on Nomad Foods to $20 and kept his Buy rating after a Q3 earnings beat. Chappell says the company saw strong organic growth in the quarter, adding that it can grow further going forward. The analyst also notes that the raised outlook for this year is likely to be "highly conservative" given that performance across the company's major geographies now looks stable while the integration of Findus deal appears to be on track.
12/07/17
UBSW
12/07/17
NO CHANGE
UBSW
U.S. consumer food forecasts need to be reduced, says UBS
UBS analyst Steven Strycula noted bearish sentiment across U.S. foods has intensified since spring as volumes remain weak among increased competition. He believes Street estimates are too optimistic despite the prospects of tax reform, citing competition, limited vendor pricing amid food cost inflation, rising supply chains costs, and private label substitution risk. Strycula noted shelf space gains are slowing and any increased shelf space has not translated into volume growth. Names in the space include Pinnacle Foods (PF), Nomad Foods (NOMD) and Mondelez (MDLZ).
COTY Coty
$14.01

-0.21 (-1.48%)

05/10/18
BMOC
05/10/18
NO CHANGE
Target $18
BMOC
Outperform
Coty price target lowered to $18 from $24 at BMO Capital
BMO Capital analyst Shannon Coyne lowered her price target on Coty to $18 after its Q3 results, saying that while earnings topped consensus thanks to stronger than expected sales in the Luxury segment, she sees Consumer Beauty business remaining weaker than anticipated. The analyst also lowered her FY19 EPS view to 86c from $1.00. Longer term, Coyne keeps her Outperform rating on Coty, stating that risk-reward on the shares is favorable as the management builds a "more focused organization closer to the customer while also digitally transforming the company."
05/11/18
DADA
05/11/18
NO CHANGE
Target $15.5
DADA
Neutral
Coty price target lowered to $15.50 at DA Davidson on 'disappointing sales'
DA Davidson analyst Linda Bolton Weiser lowered her price target on Coty to $15.50 from $19.50 and kept her Neutral rating, citing "disappointing" sales and a "very weak cash flow performance" in Q3. Weiser also attributes the revenue beat to favorable FX and acquisition growth rather than organic growth, which also missed expectations of a 2% rate at "only 0.2%".
05/11/18
DBAB
05/11/18
DOWNGRADE
Target $13
DBAB
Hold
Coty downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Faiza Alwy downgraded Coty to Hold and lowered her price target for the shares to $13 from $21. The downgrade follows the company's Q1 results.
05/10/18
BREN
05/10/18
UPGRADE
BREN
Hold
Coty upgraded to Hold from Sell at Berenberg
KORS Michael Kors
$66.83

-1.34 (-1.97%)

05/31/18
SBSH
05/31/18
NO CHANGE
Target $69
SBSH
Neutral
Michael Kors price target lowered to $69 from $75 at Citi
Citi analyst Paul Lejuez lowered his price target for Michael Kors to $69 and keeps a Neutral rating on the shares following yesterday's Q4 results. While the stock pullback is a "slight overreaction," the path to share upside "is not crystal clear," Lejuez tells investors in a research note. Further, while the company's free cash flow looks good, shareholders won't necessarily see that cash if management makes another acquisition, the analyst adds.
05/31/18
DBAB
05/31/18
NO CHANGE
Target $83
DBAB
Buy
Michael Kors selloff yesterday a buying opportunity, says Deutsche Bank
Deutsche Bank analyst Paul Trussell believes the selloff yesterday in shares of Michael Kors presents a buying opportunity. The analyst notes the Q1 earnings guidance is 6% ahead of the Street and that the company posted its first positive comp growth in two years. He continues to recommend shares of Kors with a Buy rating. Trussell trimmed his price target for Kors to $83 from $86.
05/31/18
NOMU
05/31/18
NO CHANGE
Target $80
NOMU
Buy
Michael Kors selloff brings buying opportunity, says Nomura Instinet
Nomura Instinet analyst Simeon Siegel views the post-earnings selloff yesterday in shares of Michael Kors as a buying opportunity. He points out that Kors is among the most conservative guiders in his coverage. The current risk/reward will prove attractive over the next few quarters, Siegel tells investors in a research note. He keeps a Buy rating on Michael Kors with an $80 price target.
05/31/18
NEED
05/31/18
NO CHANGE
Target $75
NEED
Buy
Michael Kors pullback a buying opportunity, says Needham
Needham analyst Rick Patel views yesterday's pullback on Michael Kors shares as a buying opportunity, calling Kors a "turnaround story with traction." In a research note to investors, Patel, who maintained a Buy rating and $75 price target, noted that Kors has a history of beating EPS targets and took a "conservative" approach to fiscal 2019 plans. He also contended that guidance for lower wholesale revenues does not reflect weak underlying demand, and sees accessories at Jimmy Choo improving as new products launch this fall.
HRL Hormel Foods
$36.11

-0.25 (-0.69%)

01/04/18
PIPR
01/04/18
INITIATION
Target $42
PIPR
Overweight
Hormel Foods assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Brett Wong assumed coverage of Hormel Foods with an Overweight rating and $42 price target. The analyst expects continued strong top-line growth, both organic and from acquisitions, and considers the company's portfolio attractive.
02/14/18
JEFF
02/14/18
UPGRADE
Target $38
JEFF
Buy
Hormel Foods upgraded to Buy from Hold at Jefferies
Jefferies analyst Akshay Jagdale upgraded Hormel Foods (HRL) to Buy with an increased price target of $38. The analyst believes the company has a "solid platform for accretive acquisitions." He also has an improved outlook for pork packer margins.
03/23/18
SPHN
03/23/18
NO CHANGE
SPHN
Stephens says to buy Hormel Foods, Tyson Foods on China trade headlines
Stephens analyst Farha Aslam recommends buying Hormel Foods (HRL) and Tyson Foods (TSN) on headlines of a Chinese 25% tariff on US pork. Aslam said China imports only about 2-3% of U.S. pork production, which is insignificant and can be absorbed by other markets.
05/24/18
SPHN
05/24/18
NO CHANGE
SPHN
Regional ban on LA poultry positive for U.S. poultry producers, says Stephens
Stephens analyst Farha Aslam noted that chicken, egg, and turkey exports had been temporarily suspended to Mexico from the U.S. since May 18 after a case of virulent Newcastle disease had been found. The newly agreed upon regional ban on poultry products from the city of Los Angeles is a positive for Pilgrim's Pride (PPC), Tyson Foods (TSN), Sanderson Farms (SAFM), Cal-Maine (CALM), and Hormel (HRL), said Aslam, but she notes the protein stocks had not traded down on the Newcastle news so she doesn't expect them to move up materially on the resolution.
EL Estee Lauder
$155.63

-1.45 (-0.92%)

05/15/18
MSCO
05/15/18
NO CHANGE
Target $162
MSCO
Overweight
Estee Lauder price target raised to $162 from $153 at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian said he believes Estee Lauder's growth potential is being undervalued despite its favorable exposure to high growth channels within the high growth prestige beauty category. Investors are still valuing Estee like a Consumer Packaged Goods company, but it should be valued versus global prestige beauty peers, contends Mohsenian. He raised his price target on the stock to $162 from $153 and keeps an Overweight rating on Estee Lauder.
05/22/18
EVER
05/22/18
INITIATION
Target $170
EVER
Outperform
Estee Laude initiated with an Outperform at Evercore ISI
05/09/18
JPMS
05/09/18
DOWNGRADE
Target $52
JPMS
Neutral
Monster Beverage downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Andrea Teixeira downgraded Monster Beverage (MNST) to Neutral and lowered her price target for the shares to $52 from $67. The analyst sees a "difficult road ahead" for the company following its Q1 results. She believes the shares will "remain challenged" until margins improve. Teixeira prefers top picks Estee Lauder (EL) and Constellation Brands (STZ) for Home and Personal Care exposure.
05/22/18
EVER
05/22/18
INITIATION
Target $170
EVER
Outperform
Estee Lauder initiated with an Outperform at Evercore ISI
As reported earlier, Evercore ISI analyst Robert Ottenstein initiated Estee Lauder with an Outperform rating and a price target of $170 as part of his broader Global Beauty sector research note. The analyst says the sector offers the "best fundamentals" within Home and Personal Care and is also "among the best" in Consumer Staples, forecasting acceleration of about 5% over the next 3 years on growth in e-commerce and expansion in China. Ottenstein notes that Estee Lauder is among the "most compelling" investment stores in the sector as a "pure-play" in high-end beauty, adding that the company's operating margins should outperform expectations with 60bp expansion. The analyst further states that Estee Lauder's investment narrative is shifting to margin upside and modest sales growth from that of declining department store sales.
CCE Coca-Cola European Partners
$39.43

0.63 (1.62%)

04/03/18
BOFA
04/03/18
NO CHANGE
BOFA
BofA/Merrill's Top 10 US Ideas for Q2 2018
BofA/Merrill introduced its Top 10 Ideas for Q2 2018. They are Buy rated Abbott (ABT), ADP (ADP),Coca-Cola European Partners (CCE), Discovery (DISCA), Dover (DOV), Lowe's (LOW), MGM Resorts (MGM), and Qualcomm (QCOM), and Underperform rated Ralph Lauren (RL) and BlackBerry (BB).
05/15/18
BOFA
05/15/18
NO CHANGE
BOFA
Coca-Cola European Partners removed from US 1 List at BofA/Merrill
04/17/18
04/17/18
UPGRADE
Target $48

Buy
Coca-Cola European Partners upgraded to Buy at Goldman Sachs
As previously reported, Goldman Sachs analyst Judy Hong upgraded Coca-Cola European Partners (CCE) to Buy, as she believes muted sentiment in the context of sugar tax implementation in the UK and France provides a compelling opportunity. Sugar tax concerns are well-known by investors, while Coca-Cola European is likely to benefit from a stable EU macro environment, innovation and expansion to improve overall portfolio mix, said Hong, who also thinks potential M&A is an underappreciated catalyst. However, she trimmed her price target on the shares to $48 from $50.
04/17/18
GSCO
04/17/18
UPGRADE
GSCO
Buy
Coca-Cola European Partners upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Judy Hong upgraded Coca-Cola European Partners to Buy.
CL Colgate-Palmolive
$63.04

-0.68 (-1.07%)

05/25/18
05/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PayPal (PYPL) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he believes PayPal is in the early stages of transforming from an online checkout company to a global payments platform. 2. Novartis (NVS) upgraded to Neutral from Underperform at Credit Suisse. 3. Colgate-Palmolive (CL) upgraded to Buy from Hold at Argus analyst John Eade saying the stock price has been dragged down to a point where the shares "offer value" given the "above market average" dividend payout and the first EPS beat in 4 quarters in the most recent earnings results. 4. Best Inc. (BSTI) upgraded to Buy from Neutral at Citi. 5. Loma Negra (LOMA) upgraded to Outperform from Market Perform at Itau BBA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
05/25/18
ARGS
05/25/18
UPGRADE
Target $72
ARGS
Buy
Colgate-Palmolive upgraded to Buy at Argus on valuation
As reported earlier, Argus analyst John Eade upgraded Colgate-Palmolive to Buy from Hold with a price target of $72. The analyst says the stock price has been dragged down to a point where the shares "offer value" given the "above market average" dividend payout and the first EPS beat in 4 quarters in the most recent earnings results. Eade further states that his $72 price target implies a multiple of 21-times forward earnings, which is still below the midpoint of the company's historical range.
05/25/18
ARGS
05/25/18
UPGRADE
ARGS
Buy
Colgate-Palmolive upgraded to Buy from Hold at Argus
05/24/18
BERN
05/24/18
NO CHANGE
Target $72
BERN
Market Perform
Colgate-Palmolive could be target for activists, says Bernstein
Bernstein analyst Ali Dibadj says his sum-of-the-parts analysis suggests Colgate-Palmolive's businesses, even beyond Oral Care, could be attractive to other owners, with areas for improvement more notably across Home Care and Pet Food. The analyst believes the company's stock could be a target for activists given its more realistic current valuation, with various levers at play to drive fundamental improvement and earnings growth. Dibadj reiterates a Market Perform rating and $72 price target on the shares.

TODAY'S FREE FLY STORIES

SLDB

Solid Biosciences

$26.73

-2.535 (-8.66%)

10:17
06/19/18
06/19
10:17
06/19/18
10:17
Hot Stocks
Breaking Hot Stocks news story on Solid Biosciences »

Solid Biosciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
06/19/18
06/19
10:17
06/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLLI

Ollie's Bargain Outlet

$74.90

-0.95 (-1.25%)

, BGS

B&G Foods

$29.95

-0.15 (-0.50%)

10:16
06/19/18
06/19
10:16
06/19/18
10:16
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

OLLI

Ollie's Bargain Outlet

$74.90

-0.95 (-1.25%)

BGS

B&G Foods

$29.95

-0.15 (-0.50%)

ITRM

Iterum Therapeutics

$12.00

0.05 (0.42%)

IR

Ingersoll-Rand

$90.52

-1.51 (-1.64%)

ALLY

Ally Financial

$25.85

-0.54 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

MAT

Mattel

$17.16

-0.62 (-3.49%)

, FFIV

F5 Networks

$177.68

-3.69 (-2.03%)

10:16
06/19/18
06/19
10:16
06/19/18
10:16
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MAT

Mattel

$17.16

-0.62 (-3.49%)

FFIV

F5 Networks

$177.68

-3.69 (-2.03%)

DPS

Dr Pepper Snapple

$121.25

-0.52 (-0.43%)

RHT

Red Hat

$171.18

-5.08 (-2.88%)

T

AT&T

$32.35

0.15 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 25

    Jul

VZ

Verizon

$47.93

0.47 (0.99%)

, INTU

Intuit

$208.59

-0.48 (-0.23%)

10:16
06/19/18
06/19
10:16
06/19/18
10:16
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

VZ

Verizon

$47.93

0.47 (0.99%)

INTU

Intuit

$208.59

-0.48 (-0.23%)

FSLR

First Solar

$51.65

-0.17 (-0.33%)

HP

Helmerich & Payne

$64.41

0.57 (0.89%)

ACN

Accenture

$161.68

-1.19 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

  • 28

    Jun

  • 10

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
06/19/18
06/19
10:16
06/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$105.48

(0.00%)

, SLDB

Solid Biosciences

$27.00

-2.265 (-7.74%)

10:15
06/19/18
06/19
10:15
06/19/18
10:15
Periodicals
Sarepta gene therapy produced 'jaw-dropping' protein increases, STAT says »

Sarepta…

SRPT

Sarepta

$105.48

(0.00%)

SLDB

Solid Biosciences

$27.00

-2.265 (-7.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PCG

PG&E

$39.96

0.18 (0.45%)

, BRK.A

Berkshire Hathaway

$285,680.00

-1460 (-0.51%)

10:15
06/19/18
06/19
10:15
06/19/18
10:15
Recommendations
PG&E, Berkshire Hathaway analyst commentary  »

PG&E would be…

PCG

PG&E

$39.96

0.18 (0.45%)

BRK.A

Berkshire Hathaway

$285,680.00

-1460 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

10:15
06/19/18
06/19
10:15
06/19/18
10:15
General news
Dallas Fed's Kaplan sees a fragile equilibrium in oil »

Dallas Fed's Kaplan…

GME

GameStop

$15.22

-0.01 (-0.07%)

, MSFT

Microsoft

$100.05

-0.83 (-0.82%)

10:14
06/19/18
06/19
10:14
06/19/18
10:14
Hot Stocks
GameStop in focus amid 'exploratory discussions' regarding potential transaction »

GameStop (GME) shares are…

GME

GameStop

$15.22

-0.01 (-0.07%)

MSFT

Microsoft

$100.05

-0.83 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

SLDB

Solid Biosciences

$28.01

-1.255 (-4.29%)

10:12
06/19/18
06/19
10:12
06/19/18
10:12
Hot Stocks
Breaking Hot Stocks news story on Solid Biosciences »

Solid Biosciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$28.16

-1.105 (-3.78%)

, SRPT

Sarepta

$105.48

(0.00%)

10:11
06/19/18
06/19
10:11
06/19/18
10:11
Hot Stocks
Breaking Hot Stocks news story on Solid Biosciences, Sarepta »

Solid Biosciences drops…

SLDB

Solid Biosciences

$28.16

-1.105 (-3.78%)

SRPT

Sarepta

$105.48

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

CBL

CBL & Associates

$5.60

-0.04 (-0.71%)

10:10
06/19/18
06/19
10:10
06/19/18
10:10
Options
CBL and Associates attracts far upside call buyers »

CBL and Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

VOYA

Voya Financial

$51.38

-0.34 (-0.66%)

10:05
06/19/18
06/19
10:05
06/19/18
10:05
Hot Stocks
Voya Financial selected as new service provider for PSERS' retirement plan »

Voya Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$274.45

-2.13 (-0.77%)

10:05
06/19/18
06/19
10:05
06/19/18
10:05
Technical Analysis
Technical Take: SPDR S&P 500 ETF near session lows after first half-hour »

The Market Vectors…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$274.45

-2.13 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTV

Cotiviti Holdings

$44.18

4.29 (10.75%)

10:03
06/19/18
06/19
10:03
06/19/18
10:03
Downgrade
Cotiviti Holdings rating change  »

Cotiviti Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$187.67

0.81 (0.43%)

10:01
06/19/18
06/19
10:01
06/19/18
10:01
Hot Stocks
Aetna plans to add up to 650 new employees in New Albany by YE20 »

Aetna announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$16.86

0.4 (2.43%)

10:01
06/19/18
06/19
10:01
06/19/18
10:01
Hot Stocks
Intrexon subsidiary announces cooperative agreement with Gates Foundation »

Oxitec, a wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONE

OneSmart Education

$12.23

-0.83 (-6.36%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
OneSmart Education falls -6.6% »

OneSmart Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$35.64

-3.765 (-9.56%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
Systemax falls -9.5% »

Systemax is down -9.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$27.97

-4.19 (-13.03%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
PagSeguro Digital falls -12.9% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$23.11

1.14 (5.19%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 5.2% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$3.13

0.68 (27.76%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Options
Notable call buying in Neptune Technologies as shares see relative strength »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$10.43

0.785 (8.14%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 7.8% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTV

Cotiviti Holdings

$44.08

4.19 (10.50%)

10:00
06/19/18
06/19
10:00
06/19/18
10:00
Hot Stocks
Cotiviti Holdings rises 10.5% »

Cotiviti Holdings is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.